Main Industry
Health Care
Main Product/Service
體訊科技股份有限公司 is primarily engaged in the sale of leukocyte reduction filters, with its main target customers being blood donation centers and medical institutions. Leukocyte reduction filters are used to filter out white blood cells from blood bags. The products sold by 體訊科技股份有限公司 include a product combination consisting of three components: the filter itself, tubing, and blood bags.
The content above was translated by Ai
Founded Year
2014
Unified Business No.
24644919
Status
Active
Number of Employees
0
Total Paid-in
Capital
7,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu City
Website
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
體訊科技股份有限公司 was officially registered on October 14, 2014, as a spin-off company of the Ministry of Science and Technology's Germination Program, "Research, Development, and Application of Blood Separation Technology — Leukocyte Reduction Series Prototypes." The members of the founding team are primarily faculty and students from Chung Yuan Christian University. Continuing the research achievements of the Germination Program team, they established this startup company to conduct the sales of leukocyte reduction filters, practically applying the results obtained from the implementation of the two-year Germination Program.
The content above was translated by Ai
